Stop advertising claims of Coronil as COVID cure until approval: AYUSH Ministry to Patanjali
authorities ordered Patanjali to stop advertising or publicizing their claims of coronil being a COVID treatment until it is fully examined and approved by the Ministry of Ayush and ICMR.
Delhi: The Indian Council of Medical Research (ICMR) and AYUSH ministry have directed Patanjali to stop advertising and publicising its claims of its medicine 'Coronil' which it claims to be a cure for coronavirus until an approval is given by the authorities.
Recently, Patanjali claimed that Coronil is effective in curing coronavirus victims; however, the ministry of Ayush on Tuesday issued a statement saying that they have taken cognizance of the news recently flashed in the media about ayurvedic medicines developed for the treatment of COVID-19 by Patanjali, Haridwar and also added that Patanjali has failed to give any details on their scientific studies regarding the medication to the authorities.
ALSO READ: Baba Ramdev claims Corona cure: All you need to know about Coronil
Hence, authorities ordered Patanjali to stop advertising or publicizing their claims of coronil being a COVID treatment until it is fully examined and approved by the Ministry of Ayush and ICMR.
Previously the Medical Dialogues team has reported that Yoga Guru Ramdev while launching Coronil said that they are "Coming up with a clinically tested, evidence-based medicine was a challenge". Patanjali claims those who administered the medicine were fully cured and none died. Ramdev even claimed that 69 percent of them recovered within 3 days. Many of the common people, as well as doctors, have been requesting ICMR to check the authenticity of Coronil. However, the ayurvedic medicines come under the authority of Ayush Ministry and they issued a statement after analyzing the claims of Patanjali.
The ministry said, "Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined."
Moreover, as Patanjali got the license from the State authorities of Uttarakhand, "the Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19."
